Skip to content

The efficacy of Rosa damascena extract in the treatment of recurrent aphthous stomatitis

The efficacy of Rosa damascena extract in the treatment of recurrent aphthous stomatitis: A randomized parallel controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138811063182N1
Enrollment
42
Registered
2010-06-06
Start date
2008-02-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent aphthous stomatitis. Recurrent oral aphthae

Interventions

Intervention 1: Placebo. Intervention 2: Rosa damascena extract 20%, 4 times per day.
Placebo
Treatment - Drugs
Rosa damascena extract 20%, 4 times per day

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The presence of at least one aphthous ulcer measuring no more than 10 mm in diameter (formation no more than 48h), had no underlying systemic or immunologic disease such as rheumatoid arthritis and behcet syndrome. Patients were excluded if they had used NSAIDs, corticosteroids or other immunoregulatory agents within 1 month prior to the study or were less than 18 years of age.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in Pain. Timepoint: on day 0 (baseline), days 4, 7, 11 and 14. Method of measurement: the Perceived Pain Rating Scale as introduced by Barker et al, 1991.;Change in Ulcer Size (mm2). Timepoint: on day 0 (baseline), days 4, 7, 11 and 14. Method of measurement: Ulcer size is measured by one examiner with the use of a calibrated dental probe with millimeter markings.;Change in number of Apthae. Timepoint: on day 0 (baseline), days 4, 7, 11 and 14. Method of measurement: Only ulcers which would come into contact with the rinse (i.e. in the oral cavity) will be considered.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKeyvan Sohrabi

Mashahd University of Medical Sciences

k1sohrabi@gmail.com+98 51 1882 9501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026